Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Gwen Fewell, PhD (she/her/hers)

SynVivo Inc., Alabama, United States

Dr Gwen Fewell is the President & CEO at SynVivo, an Organ-on-Chip company with proprietary microfluidic-based 3D Tissue and Organ-on-Chip models for drug development and personalized medicine applications.

A neuroscientist by training Gwen has spent the last 15 years in product development and commercialization at start-up, mid-size to large life science research tools companies. Previously she led global product marketing of the RNAi and Gene Expression portfolio at Thermo Scientific Genomics and was Director of Product Marketing at Open Biosystems where she led product management and marketing teams with responsibility for commercializing new gene modulation products including the first vector-based RNAi whole genome product on the market. Gwen was awarded the 2014 State of Alabama Innovation Award for Outstanding Woman in Innovation. She currently serves on the Board of Directors at BioAlabama whose mission is to connect the bioscience ecosystem in Alabama.

Gwen earned an M.S. in Neurophysiology from the University of Mumbai and a Ph.D. in Neuroscience at Florida State University. She performed postdoctoral studies at Children’s Hospital, Cincinnati exploring the genetic role of homeobox genes in brain development, and later studied the genetics of pediatric medulloblastoma in the Department of NeuroOncology at MD Anderson Cancer Center in Houston, TX.

Disclosure information not submitted.

Presentation(s):